BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28988604)

  • 21. Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice: A Sex-Specific Analysis of the CardioMEMS Post-Approval Study.
    DeFilippis EM; Henderson J; Axsom KM; Costanzo MR; Adamson PB; Miller AB; Brett ME; Givertz MM
    Circ Heart Fail; 2021 Jun; 14(6):e007892. PubMed ID: 34129363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System.
    Loh JP; Barbash IM; Waksman R
    J Am Coll Cardiol; 2013 Apr; 61(15):1571-6. PubMed ID: 23352783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late Migration of a CardioMEMS
    Rali AS; Shah Z; Sauer A; Gupta K
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28377440
    [No Abstract]   [Full Text] [Related]  

  • 24. Telemonitoring of fluid status in heart failure: CHAMPION.
    Krum H
    Lancet; 2011 Feb; 377(9766):616-8. PubMed ID: 21315440
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of implantable hemodynamic monitors to manage heart failure.
    Abraham WT
    Heart Fail Clin; 2015 Apr; 11(2):183-9. PubMed ID: 25834968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.
    Heywood JT; Jermyn R; Shavelle D; Abraham WT; Bhimaraj A; Bhatt K; Sheikh F; Eichorn E; Lamba S; Bharmi R; Agarwal R; Kumar C; Stevenson LW
    Circulation; 2017 Apr; 135(16):1509-1517. PubMed ID: 28219895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
    Bradley EA; Berman D; Daniels CJ
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):248-52. PubMed ID: 27014843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonhemodynamic parameters from implantable devices for heart failure risk stratification.
    Boehmer JP
    Heart Fail Clin; 2015 Apr; 11(2):191-201. PubMed ID: 25834969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Implantable Hemodynamic Monitors to Manage Heart Failure.
    Abraham WT
    Cardiol Clin; 2017 May; 35(2):273-279. PubMed ID: 28411901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable Hemodynamic Monitoring for Heart Failure Patients.
    Abraham WT; Perl L
    J Am Coll Cardiol; 2017 Jul; 70(3):389-398. PubMed ID: 28705321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoptysis After CardioMEMS Implantation: Case Report and Review.
    Rali AS; Shah Z; Sauer AJ; Gupta K
    Am J Case Rep; 2018 Mar; 19():382-385. PubMed ID: 29602943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expanding role of implantable devices to monitor heart failure and pulmonary hypertension.
    Yacoub MH; McLeod C
    Nat Rev Cardiol; 2018 Dec; 15(12):770-779. PubMed ID: 30367136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remote monitoring for better management of LVAD patients: the potential benefits of CardioMEMS.
    Veenis JF; Brugts JJ
    Gen Thorac Cardiovasc Surg; 2020 Mar; 68(3):209-218. PubMed ID: 31981137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Telemonitoring and pulmonary artery pressure-guided treatment of heart failure].
    Angermann CE; Rosenkranz S
    Internist (Berl); 2018 Oct; 59(10):1041-1053. PubMed ID: 30238134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wireless cardiac devices offer innovative aid to heart patients. Advanced technology expected to usher in new paradigm shift promising to improve heart failure therapy and lower health care costs.
    Heart Advis; 2011 Jan; 14(1):3. PubMed ID: 22973589
    [No Abstract]   [Full Text] [Related]  

  • 37. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.
    Benza RL; Doyle M; Lasorda D; Parikh KS; Correa-Jaque P; Badie N; Ginn G; Airhart S; Franco V; Kanwar MK; Murali S; Raina A; Agarwal R; Rajagopal S; White J; Biederman R
    Chest; 2019 Dec; 156(6):1176-1186. PubMed ID: 31265832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Implantable hemodynamic monitoring devices].
    Seifert M; Butter C
    Herz; 2015 Nov; 40(7):966-71. PubMed ID: 26462476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure.
    Verdejo HE; Castro PF; Concepción R; Ferrada MA; Alfaro MA; Alcaíno ME; Deck CC; Bourge RC
    J Am Coll Cardiol; 2007 Dec; 50(25):2375-82. PubMed ID: 18154961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device.
    Krahnke JS; Abraham WT; Adamson PB; Bourge RC; Bauman J; Ginn G; Martinez FJ; Criner GJ;
    J Card Fail; 2015 Mar; 21(3):240-9. PubMed ID: 25541376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.